Goldman Sachs Remains a Buy on Arthur J Gallagher & Co (AJG)

Goldman Sachs analyst Robert Cox CFA reiterated a Buy rating on Arthur J. Gallagher & Co (AJG) and set a $277 price target. The article cites TipRanks data on Cox’s track record and notes other analyst views: Barclays also has Buy, while KBW has Hold. It reports AJG Q1 revenue of $4.76B and net profit of $822M, up from $3.73B and $704.4M a year earlier, plus recent insider selling.

Original reporting
Published Aug 1, 2026, 12:50 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 3, 2026, 4:15 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Goldman Sachs Remains a Buy on Arthur J Gallagher & Co (AJG) — source image
Decision brief

The 30-second read

$AJGBullishLow
01

Why it matters

For AJG, the actionable element is the reiterated Buy and stated $277 price target. The insider-selling note is a secondary sentiment input, not a new regulatory or operational development.

02

Market read

This is a low-to-moderate sentiment update for AJG from sell-side coverage, with no new operational or regulatory catalyst disclosed.

03

What to watch

The article does not provide the thesis behind the $277 target or any new guidance, so traders should verify whether the target reflects updated assumptions versus a routine reiteration.

Relevance 4/10Novelty 3/10Timing: today’s analyst note reiteration and target update

Background

The piece summarizes a Goldman Sachs analyst report, references other sell-side ratings, and provides earnings and insider-sale context.

Company-level read

Ticker impact

$AJGBullishMedium confidence
Context

Goldman Sachs analyst Robert Cox maintained a Buy on Arthur J Gallagher & Co and set a $277 price target, alongside mention of recent earnings and insider selling.

Expected impact

Near-term bias modestly positive versus the market due to the reiterated Buy and explicit $277 target, but likely limited follow-through because no new company-specific event is disclosed.

Evidence & confidence

The only fresh decision-like item is the maintained Buy and target. The earnings figures and insider sale are presented as context rather than a newly disclosed filing or event in the text.

Market effects

Reiterated bullish stance on insurance brokerage can support sentiment in the broader insurance brokerage/financial services space, but the article provides no sector-wide new data.

No specific regional market catalyst beyond US-listed coverage.

No global macro or cross-border transaction details are provided.

Counterpoint

Insider selling and a KBW Hold alongside two Buy ratings suggests mixed near-term conviction; the reiterated target may not change fundamentals.

Key entities

  • Arthur J Gallagher & Co

    Subject of the article, covered by Goldman Sachs with a maintained Buy and $277 price target; includes earnings context and insider selling.

  • Goldman Sachs

    Issued the report cited, with analyst Robert Cox maintaining Buy and setting a $277 price target.

  • Robert Cox CFA

    Goldman Sachs analyst who maintained the Buy rating and provided the $277 target.

  • KBW

    Maintained a Hold rating on AJG in a report issued the same day.

Related articles

$AJGMedAI 8/10

Arthur J. Gallagher & Co. Acquires Apollo Insurance Solutions Ltd.

Arthur J. Gallagher & Co. (NYSE:AJG) said it will acquire Vancouver-based Apollo Insurance Solutions Ltd., a Canadian digital insurance broker and MGA focused on tenant insurance. The deal terms were not disclosed. Apollo’s team will remain in Vancouver under Gallagher’s Canadian retail property/casualty leadership, aiming to expand Gallagher’s Canada capabilities.

$AJGMed

Gallagher posts revenue increase of 24% to $4bn for Q2'26

Insurance broking group Arthur J. Gallagher & Co. has reported total revenue before reimbursement of USD 3.955 billion for the second quarter of 2026, compared to USD 3.2 billion in Q2’25, as the combined brokerage and risk management segments delivered 24% total revenue growth, including organic growth of 6%.

$AJGMed

Gallagher's Q2 revenue jumps 24% as organic growth holds at 6%

Arthur J. Gallagher & Co. reported revenue before reimbursements of $3.955 billion for the quarter ended June 30, 2026, up 24% from $3.179 billion a year earlier, as the global insurance brokerage's combined Brokerage and Risk Management segments grew 6% on an organic basis. Organic growth holds steady while acquisition pace slows "We delivered an excellent second quarter," said J. Patrick Gallagher Jr., chairman and CEO.

$AJGMed

Gallagher (AJG) Q2 2026 Earnings Call Transcript

Thursday, July 30, 2026 at 5:15 p.m. ET CALL PARTICIPANTS Chairman and Chief Executive Officer - J. Patrick Gallagher, Jr. Chief Financial Officer - Doug Howell TAKEAWAYS Total Revenue Growth -- 24% for the combined brokerage and risk management segments of Arthur J. Gallagher & Co. (AJG -4.63%), reflecting contributions from both organic expansion and the integration of AssuredPartners.

$AJGMed

Arthur J. Gallagher Reports Lower Q2 Profit

DoArthur J. Gallagher Reports Lower Q2 ProfitWASHINGTON (dpa-AFX) - Arthur J. Gallagher (AJG) reported on Thursday total revenue of $4.00 billion for the second quarter of 2026, up from $3.22 billion in the same period last year.Net earnings... ► Artikel lesenDoArthur J.Gallagher GAAP EPS of $1.25 misses by $0.50, revenue of $3.5B misses by $540M